Is daily use of chlorhexidine (CHG) gluconate on the body appropriate, or should it be limited to areas around invasive devices like tubes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Chlorhexidine Gluconate Use: Body-Wide vs. Tube-Site Application

Daily chlorhexidine gluconate (CHG) bathing is recommended for ICU patients over two months of age, while for non-ICU patients and around tubes/catheters, CHG should be used specifically at insertion sites and during site care. 1

Recommendations for CHG Use in Different Settings

ICU Patients

  • Daily chlorhexidine bathing is recommended for ICU patients over two months of age to reduce central line-associated bloodstream infections (CLABSI) 1
  • Multiple studies have demonstrated significant reduction in skin colonization with potential pathogens and decreased risk of catheter-related infections with daily CHG bathing in ICU settings 2
  • The 2% CHG in 70% isopropyl alcohol formulation has shown the greatest efficacy in reducing infection rates 1

Non-ICU Patients

  • The effectiveness of routine daily CHG bathing in non-ICU patients remains uncertain and is not strongly supported by current evidence 1
  • For non-ICU patients, CHG use should be focused on specific sites where invasive devices are present rather than routine whole-body application 1

Around Tubes and Catheters

  • CHG (2% in 70% isopropyl alcohol) should be used for skin preparation before catheter insertion and for cleaning catheter exit sites 1
  • For central venous catheters, CHG should be applied to the insertion site and allowed to air dry before catheter insertion or dressing application 1
  • CHG-impregnated dressings are effective in reducing extraluminal contamination at catheter exit sites and should be considered for patients with non-tunneled central venous catheters at high risk for infection 1

Special Considerations and Precautions

Pediatric and Neonatal Patients

  • CHG use is not recommended in infants younger than two months due to potential adverse effects 1
  • Life-threatening skin injuries have been reported in infants with birth weight below 1,000 grams who are less than 7 days postnatal age 1, 3
  • For neonates, alternative antiseptics should be considered based on clinical judgment 4

Safety Considerations

  • CHG is for external use only and should be kept away from eyes, ears, and mouth 5
  • It may cause serious and permanent eye injury if placed in the eye during procedures 5
  • CHG should not be used on wounds involving more than superficial layers of skin 5
  • Discontinue use if irritation, sensitization, or allergic reaction occurs 5

Application Techniques

For Catheter Sites

  • Before accessing catheters, disinfect the catheter hubs, connectors, and injection ports with 2% CHG in 70% isopropyl alcohol 1
  • Allow the antiseptic solution to completely air dry before accessing the site 1
  • For non-tunneled central venous catheters, the exit site should preferably be covered with a sterile, transparent, semi-permeable polyurethane dressing, which should be changed every 7 days 1

For Daily Bathing (ICU Patients)

  • Use no-rinse, 2% CHG-impregnated cloths for daily patient cleansing in ICU settings 2
  • Ensure thorough application to all skin surfaces except face, mucous membranes, and non-intact skin 2
  • Do not rinse off after application; allow to air dry 2

Common Pitfalls to Avoid

  • Using CHG for repeated general skin cleansing of large body areas outside of ICU settings without clear indication 5
  • Applying CHG to mucous membranes or sensitive areas like eyes, ears, and genitals 5
  • Failing to allow CHG to completely dry before inserting catheters or applying dressings 1
  • Using CHG in infants younger than two months without considering alternatives 1, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Safety of chlorhexidine gluconate used for skin antisepsis in the preterm infant.

Journal of perinatology : official journal of the California Perinatal Association, 2012

Research

Chlorhexidine Gluconate Utilization for Infection Prevention in the NICU: A Survey of Current Practice.

Advances in neonatal care : official journal of the National Association of Neonatal Nurses, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.